About tobramyci n
Aminoglycoside antibiotic
Used for
- Treats chronic Pseudomonas lung infection in people with cystic fibrosis.
Usual adult dose
For cystic fibrosis: 300 mg by nebuliser twice daily for 28 days, followed by 28 days off; repeat cycles.
Usual dose in children
For cystic fibrosis from age 6 years: 300 mg by nebuliser twice daily for 28 days, followed by 28 days off; repeat cycles.
Common side effects
- Cough, hoarse voice, or throat irritation
- Breathlessness or wheezing
- Ringing in the ears or hearing changes
- Taste disturbance
Important warnings
- Can affect hearing, balance, or kidney function; monitoring may be needed.
- May cause bronchospasm, especially in people with asthma.
- Use only with a suitable nebuliser; do not swallow or mix with other medicines.
- Not suitable for inhalation with certain nebulisers; follow product instructions.
Pregnancy
Use during pregnancy only if clearly needed; discuss potential risks with a healthcare professional.
Breastfeeding
Systemic absorption after inhalation is low, but use during breastfeeding should be assessed by a healthcare professional.
Interactions
- Other medicines that can harm hearing or kidneys, including aminoglycoside antibiotics
- Loop diuretics such as furosemide
- Neuromuscular-blocking medicines or other drugs affecting muscle function
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.